403 related articles for article (PubMed ID: 14679180)
41. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
[TBL] [Abstract][Full Text] [Related]
42. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
[TBL] [Abstract][Full Text] [Related]
43. Schwann cell preparation from single mouse embryos: analyses of neurofibromin function in Schwann cells.
Ratner N; Williams JP; Kordich JJ; Kim HA
Methods Enzymol; 2006; 407():22-33. PubMed ID: 16757311
[TBL] [Abstract][Full Text] [Related]
44. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.
Choi K; Komurov K; Fletcher JS; Jousma E; Cancelas JA; Wu J; Ratner N
Sci Rep; 2017 Mar; 7():43315. PubMed ID: 28256556
[TBL] [Abstract][Full Text] [Related]
45. Mast cells and the neurofibroma microenvironment.
Staser K; Yang FC; Clapp DW
Blood; 2010 Jul; 116(2):157-64. PubMed ID: 20233971
[TBL] [Abstract][Full Text] [Related]
46. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
47. It takes a (dysfunctional) village to raise a tumor.
Reilly KM; Van Dyke T
Cell; 2008 Oct; 135(3):408-10. PubMed ID: 18984150
[TBL] [Abstract][Full Text] [Related]
48. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
49. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
[TBL] [Abstract][Full Text] [Related]
50. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas.
Peltonen S; Kallionpää RA; Peltonen J
Exp Dermatol; 2017 Jul; 26(7):645-648. PubMed ID: 27622733
[TBL] [Abstract][Full Text] [Related]
51. Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.
Harigai R; Sakai S; Nobusue H; Hirose C; Sampetrean O; Minami N; Hata Y; Kasama T; Hirose T; Takenouchi T; Kosaki K; Kishi K; Saya H; Arima Y
Sci Rep; 2018 Apr; 8(1):6069. PubMed ID: 29666462
[TBL] [Abstract][Full Text] [Related]
52. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
[TBL] [Abstract][Full Text] [Related]
53. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
Elife; 2022 Mar; 11():. PubMed ID: 35311647
[TBL] [Abstract][Full Text] [Related]
54. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.
Kawachi Y; Maruyama H; Ishitsuka Y; Fujisawa Y; Furuta J; Nakamura Y; Ichikawa E; Furumura M; Otsuka F
Exp Dermatol; 2013 Apr; 22(4):262-5. PubMed ID: 23528211
[TBL] [Abstract][Full Text] [Related]
55. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
[TBL] [Abstract][Full Text] [Related]
56. Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve.
Ribeiro S; Napoli I; White IJ; Parrinello S; Flanagan AM; Suter U; Parada LF; Lloyd AC
Cell Rep; 2013 Oct; 5(1):126-36. PubMed ID: 24075988
[TBL] [Abstract][Full Text] [Related]
57. Gene-targeted deletion of neurofibromin enhances the expression of a transient outward K+ current in Schwann cells: a protein kinase A-mediated mechanism.
Xu Y; Chiamvimonvat N; Vázquez AE; Akunuru S; Ratner N; Yamoah EN
J Neurosci; 2002 Nov; 22(21):9194-202. PubMed ID: 12417644
[TBL] [Abstract][Full Text] [Related]
58. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.
Le LQ; Shipman T; Burns DK; Parada LF
Cell Stem Cell; 2009 May; 4(5):453-63. PubMed ID: 19427294
[TBL] [Abstract][Full Text] [Related]
59. EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.
Wu J; Liu W; Williams JP; Ratner N
Oncogene; 2017 Mar; 36(12):1669-1677. PubMed ID: 27748759
[TBL] [Abstract][Full Text] [Related]
60. Long-term culture and characterization of human neurofibroma-derived Schwann cells.
Rosenbaum T; Rosenbaum C; Winner U; Müller HW; Lenard HG; Hanemann CO
J Neurosci Res; 2000 Sep; 61(5):524-32. PubMed ID: 10956422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
